Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Pathogenic Variants in ATP1A3: Why Is There So Much Confusion?
Journal: Neurology. Genetics
Published: April 16, 2025
Structural Alterations in the Gray Matter Volume in Rapid-Onset Dystonia-Parkinsonism.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: October 02, 2024
Neurological and psychiatric characterization of rapid-onset dystonia-parkinsonism over time.
Journal: Parkinsonism & related disorders
Published: June 11, 2024
The vital role of natural history studies in rare disease: insights from X-linked dystonia parkinsonism.
Journal: Brain communications
Published: March 27, 2023
Rapid-onset dystonia-parkinsonism is associated with reduced cerebral blood flow without gray matter changes.
Journal: Frontiers in neurology
Published: December 05, 2022
Temperature instability of a mutation at a multidomain junction in Na,K-ATPase isoform ATP1A3 (p.Arg756His) produces a fever-induced neurological syndrome.
Journal: The Journal of biological chemistry
Published: July 01, 2022
Aligning academic medicine within the healthcare system: the APS-SPR virtual chat series.
Journal: Pediatric research
Published: October 23, 2021
Predictive modeling of spread in adult-onset isolated dystonia: Key properties and effect of tremor inclusion.
Journal: European journal of neurology
Published: May 18, 2021
AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions.
Journal: Clinical parkinsonism & related disorders
Published: May 12, 2021
Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin A: Findings from the prospective, observational Upper Limb International Spasticity (ULIS-III) cohort study.
Journal: Journal of rehabilitation medicine
Published: February 22, 2021
Last Updated: 09/26/2026